Abstract:Matrix metalloproteinase (MMP) 2, MMP7 and MMP9 are important members of the MMP family. Four polymorphisms in the promoter region of these MMPs, which are MMP2 -1306 C > T, MMP2 -735 C > T, MMP7 -181 A > G and MMP9 -1562 C > T, have been reported to be functional and may contribute to genetic susceptibility to cancers. However, the associations between these polymorphisms and cancer risk remain inconclusive due to conflicting results from different case-control studies. To better evaluate the role of these polymorphisms in cancer development, we conducted a meta-analysis that included 51 studies, with more than 40 000 subjects. The results showed that under dominant genetic model, MMP2 -1306 T was associated with lower susceptibility to lung cancer [odds ratio (OR) = 0.50, 95% confidence interval (CI) 0.43-0.59, P-heterogeneity = 0.147, I-2 = 44.1%], head and neck cancer (OR = 0.53, 95% CI 0.41-0.69, P-heterogeneity = 0.974, I-2 = 0.0%) and oesophageal cancer (OR = 0.67, 95% CI 0.55-0.80, P-heterogeneity = 0.593, I-2 = 0.0%); MMP2-735T was associated with lower risk in lung cancer (OR = 0.65, 95%CI 0.53-0.79, P-heterogeneity = 0.42, I-2 = 0.0%) and oesophageal cancer (OR = 0.84, 95% CI 0.70-0.99, P-heterogeneity = 0.206, I-2 = 37.4%); MMP7 -181 AG and GG genotype carriers had an increased gastric cancer risk (OR = 1.90, 95% CI 1.43-2.51, P-heterogeneity = 0.992, I-2 = 0.0%) and MMP9 -1562 C > T was not associated with cancer risk in the whole group analysis (OR = 0.99, 95% CI 0.91-1.08, P-heterogeneity = 0.419, I-2 = 3.0%) and subgroup analyses. In all, our meta-analysis suggests that MMP2 -1306 C > T, MMP2 -735 C > T and MMP7 -181 A > G may play allele-specific roles in cancer development, while MMP9 -1562 C > T may not be a major risk factor for most cancer types. Large case-control studies should be performed to clarify the possible roles of these four polymorphisms in different kinds of cancer in more detail.

The Contribution of Matrix Metalloproteinase-7 Promoter Genotypes in Breast Cancer in Taiwan

The Association of Matrix Metalloproteinase-8 Promoter Genotypes in Breast Cancer

The Association of Matrix Metalloproteinase-1 Promoter Polymorphisms with Breast Cancer.

Contribution of matrix metalloproteinases-1 genotypes to gastric cancer susceptibility in Taiwan

Association of Matrix Metalloproteinase‐2 and ‐9 Promoter Polymorphisms with Colorectal Cancer in Chinese

A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-2 Promoter is Associated with Colorectal Cancer.

[The Correlation Between Polymorphisms of Matrix Metalloproteinase-2 and -9 Genes and Colorectal Cancer of Chinese Patients].

Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.

Common Mmp-7 Polymorphisms and Breast Cancer Susceptibility: A Multistage Study of Association and Functionality

Genetic Polymorphisms in the Mmp-7 Gene and Breast Cancer Survival

No Association Between the Polymorphisms in Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Promoter Regions and Colorectal Cancer in Chinese

Impacts of Matrix Metalloproteinase-2 Promoter Genotypes on Breast Cancer Risk

The Association of MMP9 Promoter Rs3918242 Genotype With Gastric Cancer

Association Between the Functional Polymorphism in the Matrix Metalloproteinase-7 Promoter and Susceptibility to Adult Astrocytoma

Contribution of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 to Upper Tract Urothelial Cancer Risk in Taiwan

The Impact of Matrix Metalloproteinase-11 Polymorphisms on Colorectal Cancer Progression and Clinicopathological Characteristics

Matrix Metalloproteinase-2 Polymorphisms and Breast Cancer Susceptibility

Polymorphisms in the Promoter Regions of Matrix Metalloproteinases 1 and 3 and Cancer Risk: A Meta-Analysis of 50 Case-Control Studies

Impact of Matrix Metalloproteinase-8 Polymorphisms on Nasopharyngeal Carcinoma Risk

Correlation Between A Single Nucleotide Polymorphism In The Matrix Metalloproteinase-2 Promoter And Risk Of Lung Cancer

Functional Polymorphisms in the Promoters of MMP-1, MMP-2, MMP-3, MMP-9, MMP-12 and MMP-13 Are Not Associated with Hepatocellular Carcinoma Risk